切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2020, Vol. 16 ›› Issue (03) : 309 -315. doi: 10.3877/cma.j.issn.1673-5250.2020.03.008

所属专题: 文献

论著

子宫腺肌病患者CXCL12/CXCR4/CXCR7 mRNA及其蛋白表达水平
赵秀敏1,(), 李杰2, 彭洋颖1, 姜健慧1   
  1. 1. 台州市第一人民医院妇产科,浙江 318020
    2. 台州市第一人民医院中心实验室,浙江 318020
  • 收稿日期:2019-11-16 修回日期:2020-05-20 出版日期:2020-06-01
  • 通信作者: 赵秀敏

CXL12/CXCR4/CXCR7 mRNA and its protein expression levels in adenomyosis patients

Xiumin Zhao1,(), Jie Li2, Yangying Peng1, Jianhui Jiang1   

  1. 1. Department of Obstetrics and Gynecology, Taizhou First People′s Hospital, Taizhou 318020, Zhejiang Province, China
    2. Central Laboratory, Taizhou First People′s Hospital, Taizhou 318020, Zhejiang Province, China
  • Received:2019-11-16 Revised:2020-05-20 Published:2020-06-01
  • Corresponding author: Xiumin Zhao
  • About author:
    Corresponding author: Zhao Xiumin, Email:
  • Supported by:
    National Natural Science Foundation of China for Youth(81801424); Medical Science and Technology Plan Project of Zhejiang Province(2015KYB-429); Project of Taizhou Science and Technology Bureau(1402ky23)
引用本文:

赵秀敏, 李杰, 彭洋颖, 姜健慧. 子宫腺肌病患者CXCL12/CXCR4/CXCR7 mRNA及其蛋白表达水平[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(03): 309-315.

Xiumin Zhao, Jie Li, Yangying Peng, Jianhui Jiang. CXL12/CXCR4/CXCR7 mRNA and its protein expression levels in adenomyosis patients[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2020, 16(03): 309-315.

目的

探讨CXCL12/CXCR4/CXCR7 mRNA及其蛋白在子宫腺肌病(AM)患者子宫内膜与肌层组织的表达及其临床意义。

方法

选择2016年1月至2017年12月,于台州市第一人民医院妇产科接受子宫全切及次全切术或病灶切除术,并经术后组织病理学检查确诊为AM的30例患者为研究对象,纳入研究组(n=30)。选择同期于同一家医院接受子宫全切及次全切术,并经术后组织病理学检查确诊为子宫肌瘤的30例患者作为对照,纳入对照组(n=30)。研究组患者术中留取在位子宫内膜及含异位病灶子宫肌层组织,对照组患者术中留取在位子宫内膜及子宫正常肌层组织,采用实时荧光定量PCR和Western blotting,分别检测子宫内膜及肌层组织中CXCL12/CXCR4/CXCR7 mRNA及其蛋白表达水平。采用成组t检验,对2组患者CXCL12/CXCR4/CXCR7 mRNA及其蛋白相对表达水平进行比较。本研究遵循的程序符合病例收集医院人体试验委员会所制定的伦理学标准,得到该委员会批准(审批文号:2015-KY004-08),并与受试者签署临床研究知情同意书。2组患者年龄等一般临床资料比较,差异无统计学意义(P>0.05)。

结果

①研究组患者在位子宫内膜及子宫肌层组织CXCL12 mRNA表达水平,分别为(0.05±0.01)与(0.24±0.03),均显著高于对照组的(0.02±0.01)与(0.11±0.02),并且差异均有统计学意义(t=2.707、P=0.014,t=3.196、P=0.009)。研究组患者在位子宫内膜组织CXCR7 mRNA表达水平为(0.007±0.002),显著高于对照组的(0.002±0.000),并且差异有统计学意义(t=2.226、P=0.035);而在2组患者子宫肌层组织的表达水平比较,则差异无统计学意义(P>0.05)。2组患者在位子宫内膜及子宫肌层组织CXCR4 mRNA表达水平分别比较,差异均无统计学意义(P>0.05)。②2组患者在位子宫内膜及子宫肌层组织CXCL12蛋白表达水平分别比较,差异均无统计学意义(P>0.05)。研究组患者在位子宫内膜组织CXCR7蛋白表达水平为(0.88±0.19),显著高于对照组的(0.72±0.17),而在子宫肌层组织的表达水平为(0.69±0.21),显著低于对照组的(1.09±0.29),2组分别比较,差异均有统计学意义(t=2.016、P=0.046,t=-2.807、P=0.019)。研究组患者在位子宫内膜组织的CXCR4蛋白表达水平为(2.08±0.27),显著低于对照组的(2.99±0.87),并且差异有统计学意义(t=-2.228、P=0.036),而2组患者子宫肌层的表达水平比较,差异无统计学意义(P>0.05)。

结论

CXCL12/CXCR4/CXCR7在AM的发生、发展中发挥作用,其机制可能与CXCR7有关。CXCL12在AM发病中存在转录后调节。

Objective

To explore the expression and clinical significance of CXCL12/CXCR4/CXCR7 mRNA and its protein in endometrium and myometrium of patients with adenomyosis (AM).

Methods

From January 2016 to December 2017, a total of 30 patients who underwent total or subtotal hysterectomy or lesion resection and were diagnosed as AM by histopathological examination in Department of Obstetrics and Gynecology, Taizhou First People′s Hospital were selected as research subjects and were enrolled into study group (n=30). Another 30 patients who underwent total or subtotal hysterectomy and were diagnosed as uterine fibroids by histopathological examination in the same hospital during the same period were selected as control and enrolled into control group (n=30). In study group, eutopic endometrium tissues and myometrium tissues with ectopic lesions were retained during operation. In control group, the eutopic endometrium and normal myometrium tissues were retained during operation. CXCL12/CXCR4/CXCR7 mRNA and its protein expression levels in tissues of two groups were evaluated by real-time fluorescence quantitative PCR and Western blotting methods, and were compared by independent-samples t test. This study was approved by the Ethics Committee of Taizhou First People′s Hospital (Approval No. 2015-KY004-08). Informed consents were obtained from all subjects. There were no statistically significant differences in general clinical data between two groups, such as age and so on (P>0.05).

Results

①The expression levels of CXCL12 mRNA in eutopic endometrium tissue and myometrium tissue with ectopic foci of study group were (0.05±0.01) and (0.24±0.03) respectively, which were both significantly higher than those of control group (0.02±0.01) and (0.11±0.02), and both the differences were statistically significant (t=2.707, P=0.014; t=3.196, P=0.009). Expression level of CXCR7 mRNA in eutopic endometrium tissue of study group was (0.007±0.002), which was significantly higher than that of control group (0.002±0.000), and the difference was statistically significant (t=2.226, P=0.035), while there was no statistical difference between two groups in expression level of CXCR4 mRNA in myometrium tissue (P>0.05). ②There were no statistical differences between two groups in expression levels of CXCL12 protein both in eutopic endometrium and myometrium tissues (P>0.05). Expression level of CXCR7 protein in eutopic endometrium tissue of study group was (0.88±0.19), which was significantly higher than that of control group (0.72±0.17), while expression level in myometrium tissue was (0.69±0.21), which was significantly lower than that of control group (1.09±0.29), and both the differences were statistically significant (t=2.016, P=0.046; t=-2.807, P=0.019). Expression level of CXCR4 protein in eutopic endometrium tissue of study group was (2.08±0.27), which was significantly lower than that of control group (2.99±0.87), and the difference was statistically significant (t=-2.228, P=0.036), while expression level of CXCR4 protein in myometrium tissue of two groups were not statistically significant (P>0.05).

Conclusions

CXCL12/CXCR4/CXCR7 plays a role in the occurrence and development of AM, and its mechanism may be related to CXCR7. The expression of CXCL12 in AM shows regulation at transcriptional level.

表1 CXCL12/CXCR4/CXCR7引物序列
图1 2组患者在位子宫内膜与子宫肌层组织CXCL12 mRNA相对表达水平比较(图1A:在位子宫内膜组织CXCL12 mRNA相对表达水平比较;图1B:子宫肌层组织CXCL12 mRNA相对表达水平比较)
图2 2组患者在位子宫内膜与子宫肌层组织CXCR4 mRNA相对表达水平比较(图2A:在位子宫内膜组织CXCR4 mRNA相对表达水平比较;图2B:子宫肌层组织CXCR4 mRNA相对表达水平比较)
图3 2组患者在位子宫内膜与子宫肌层组织CXCR7 mRNA相对表达水平比较(图3A:在位子宫内膜组织CXCR7 mRNA相对表达水平比较;图3B:子宫肌层组织CXCR7 mRNA相对表达水平比较)
图4 2组患者在位子宫内膜与子宫肌层组织CXCL12/CXCR4/CXCR7蛋白Western blotting检测结果图(图4A:在位子宫内膜组织检测结果图;图4B:子宫肌层组织检测结果图)
表2 2组患者子宫内膜与肌层组织CXCL12/CXCR4/CXCR7蛋白相对表达量比较(±s)
[1]
Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: an update [J]. Fertil Steril, 2012, 98(3): 572-529. DOI: 10.1016/j.fertnstert.2012.06.044.
[2]
Walentowicz-Sadlecka M, Sadlecki P, Bodnar M, et al. Stromal derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 in endometrial cancer patients [J]. PLoS One, 2014, 9(1): e84629. DOI: 10.1371/journal.pone.0084629.
[3]
Leconte M, Chouzenoux S, Nicco C, et al. Role of the CXCL12-CXCR4 axis in the development of deep rectal endometriosis [J]. J Reprod Immunol, 2014, 103: 45-52. DOI: 10.1016/j.jri.2013.12.121.
[4]
吴唯,钱立元,戴荆,等. 不同分子分型乳腺癌组织中趋化因子CXCL12及其受体CXCR4和CXCR7的表达及临床意义[J]. 中南大学学报(医学版), 2017, 42(2): 147-153. DOI: 10.11817/j.issn.1672-7347.2017.02.005.
[5]
Li J, Yin G, Chen M, et al. Expression of CXCL12 and its receptor CXCR4 in patients with adenomyosis [J]. Oncol Lett, 2017, 13(4): 2731-2736. DOI: 10.3892/ol.2017.5762.
[6]
Hara T, Tanegashima K. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis [J]. Biomol Concepts, 2014, 5(2): 167-173. DOI: 10.1515/bmc-2014-0007.
[7]
Krikun G. The CXL12/CXCR4/CXCR7 axis in female reproductive tract disease: review [J]. Am J Reprod Immunol, 2018, 80(5): e13028. DOI: 10.1111/aji.13028.
[8]
谢幸,孔北华,段涛. 妇产科学[M]. 9版. 北京:人民卫生出版社,2018: 268, 304.
[9]
Huang TS, Chen YJ, Chou TY, et al. Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells [J]. J Cell Mol Med, 2014, 18(7): 1358-1371. DOI: 10.1111/jcmm.12300.
[10]
Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis [J]. Hum Reprod Update, 2014, 20(3): 386-402. DOI: 10.1093/humupd/dmt052.
[11]
Tsutsumi A, Okada H, Nakamoto T, et al. Estrogen induces stromal cell-derived factor 1 (SDF-1/CXCL12) production in human endometrial stromal cells: a possible role of endometrial epithelial cell growth [J]. Fertil Steril, 2011, 95(1): 444-447. DOI: 10.1016/j.fertnstert.2010.08.037.
[12]
Zheng N, Chen J, Li T, et al. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention [J]. Mol Carcinog, 2017, 56(8): 1896-1908. DOI: 10.1002/mc.22645.
[13]
Zhou WH, Wu X, Hu WD, et al. Co-expression of CXCR4 and CXCR7 in human endometrial stromal cells is modulated by steroid hormones [J]. Int J Clin Exp Pathol, 2015, 8(3): 2449-2460.
[14]
Uto-Konomi A, McKibben B, Wirtz J, et al. CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4 [J]. Biochem Biophys Res Commun, 2013, 431(4): 772-776. DOI: 10.1016/j.bbrc.2013.01.032.
[15]
Han Y, Wu C, Wang J, et al. CXCR7 maintains osteosarcoma invasion after CXCR4 suppression in bone marrow microenvironment [J]. Tumour Biol, 2017, 39(5): 1010428317701631. DOI: 10.1177/1010428317701631.
[16]
谢江柳,师水生. CXCL12/CXCR4轴与肿瘤侵袭转移关系的研究进展[J]. 医学综述,2014, 20(23): 4269-4271. DOI: 10.3969/j.issn.1006-2084.2014.23.018.
[17]
Zabel BA, Lewén S, Berahovich RD, et al. The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells [J]. Mol Can, 2011, 10: 73. DOI: 10.1186/1476-4598-10-73.
[1] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[2] 林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[3] 王璐, 樊杨. 子宫内膜癌相关生物标志物研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 511-516.
[4] 罗丹, 孔为民, 陈姝宁, 赵小玲, 谢云凯. 子宫内膜异位症患者在位及异位内膜上皮细胞-间充质转化相关生物标志物的变化[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 530-539.
[5] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[6] 代雯荣, 赵丽娟, 李智慧. 细胞外囊泡对胚胎着床影响的研究进展[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 616-620.
[7] 周东杰, 蒋敏, 范海瑞, 高玲玲, 孔祥, 卢丹, 王丽萍. 非编码RNA在卵泡发育成熟中作用及其机制的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 387-393.
[8] 陈荟竹, 郭应坤, 汪昕蓉, 宁刚, 陈锡建. 上皮性卵巢癌"二元论模型"的分子生物学研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 394-402.
[9] 韩春颖, 王婷婷, 李艳艳, 朴金霞. 子宫内膜癌患者淋巴管间隙浸润预测因素研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 403-409.
[10] 杨一君, 董雯, 刘晓平, 石灿, 张磊, 谷琎, 龚咪, 华馥. 腹腔镜折叠对接缝合联合宫腔镜憩室开渠法治疗剖宫产瘢痕憩室的疗效[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 330-337.
[11] 罗皓天, 陈丹莹, 王伟财, 周晨. 基质细胞衍生因子1/CXC趋化因子受体4轴在骨免疫相关疾病中的研究进展[J]. 中华口腔医学研究杂志(电子版), 2023, 17(03): 218-227.
[12] 王细文, 刘恒炜, 黄桔园, 易跃雄, 张蔚. 单孔腹腔镜UGF两翼法腹主动脉旁淋巴结切除术[J]. 中华腔镜外科杂志(电子版), 2023, 16(04): 246-248.
[13] 罗曼文, 黄桔园, 刘艳燕, 易跃雄, 陈雨柔, 熊家强, 王景涛, 张蔚. 单孔腹腔镜子宫肌瘤旋切隔离保护技术的应用[J]. 中华腔镜外科杂志(电子版), 2023, 16(04): 220-226.
[14] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[15] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
阅读次数
全文


摘要